Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

Autor: Reichardt, P. *, von Minckwitz, G., Thuss-Patience, P.C., Jonat, W., Kölbl, H., Jänicke, F., Kieback, D.G., Kuhn, W., Schindler, A.E., Mohrmann, S., Kaufmann, M., Lück, H.J.
Zdroj: In Annals of Oncology August 2003 14(8):1227-1233
Databáze: ScienceDirect